|
|
Home > Healthcare > Biotechnology > General Biotech
Covance Inc.
|
| Published Date:
October 2009
Published By:
SGA Lists
Page Count:
3
Order Code:
R406-16599
|
|
| Covance develops and carries out preclinical and clinical trials of potential commercial drugs. Services include toxicology studies, biostatistical analysis, clinical data management, and study design and monitoring. Covance will also assist a company in moving a drug through the regulatory approval process. Among the company`s customers are pharmaceutical, biotech, and medical device firms; it also offers laboratory testing services to companies in the chemical, agrochemical, and food industries
|
Similar Products
• Algae For Fuel, Algal Oil, Biofuels, Biodiesel, Ethanol And The Future Of Petroleum And Green Energy
Published Nov 2009 by Amadee & Company
• Biotechnology (Pharmaceuticals) Report
Published Nov 2009 by Plimsoll Publishing Ltd.
• Opportunities in Human Embryonic Stem Cell (hESC) Products
Published Nov 2009 by BioInformant Worldwide, L.L.C.
• Global Stem Cell and Advanced Technologies Market
Published Nov 2009 by MarketsandMarkets
• Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB
• Acorda Therapeutics, Inc. - SWOT Analysis
Published Oct 2009 by Datamonitor
• Future of Green Biotechnology in China
Published Oct 2009 by CCM International Limited
• Scientific Research in Australia - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Biotechnology in Australia - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Biotechnology in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
|
|
|
|
0 items
